Ikuta, Shoko
Saito, Yutaka
Takata, So
Nakatani, Yoichiro
Nagatomo, Izumi
Shiba, Satoshi
Takeda, Yoshito
Totoki, Yasushi
Mizutani, Sayaka
Sunakawa, Hironori
Ikematsu, Hiroaki
Takamaru, Hiroyuki
Kumanogoh, Atsushi
Yachida, Shinichi
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP22ck0106546)
Japan Agency for Medical Research and Development (JP21cm0106477)
Japan Agency for Medical Research and Development (JP23ama221404)
Japan Agency for Medical Research and Development (JP22ck0106546)
Japan Society for the Promotion of Science (20H03662)
Takeda Science Foundation (NA)
Yasuda Memorial Medical Foundation (NA)
Mitsubishi Foundation (NA)
Princess Takamatsu Cancer Research Fund (NA)
Yakult Bio-Science Foundation (NA)
Article History
Received: 8 September 2024
Accepted: 15 October 2024
First Online: 7 November 2024
Declarations
:
: This study was approved by the Research Ethics Committees of the National Cancer Center, Osaka University and Tokyo Institute of Technology as meeting the ethical guidelines for medical and health research involving human individuals (National Cancer Center, 2018-009; Osaka University, 20218: Tokyo Institute of Technology, 2014018).
: The authors declare no competing interests.